Cas no 155306-71-1 (Coumarin 545T)

Coumarin 545T structure
Coumarin 545T structure
Product Name:Coumarin 545T
CAS No:155306-71-1
MF:C26H26N2O2S
MW:430.561845302582
MDL:MFCD03427187
CID:65399
PubChem ID:24879682
Update Time:2025-11-02

Coumarin 545T Chemical and Physical Properties

Names and Identifiers

    • C545T
    • 10-(2-Benzothiazolyl)-2,3,6,7-tetrahydro-1,1,7,7-tetramethyl-1H,5H,11H-(1)benzopyropyrano(6,7-8-I,j)quinolizin-11-one
    • 10-(2-BENZOTHIAZOLYL)-2 3 6 7-TETRAHYDR&
    • 10-(2-Benzothiazolyl)-2,3,6,7-tetrahydro-1,1,7,7,-tetramethyll-1H,5H,11H-1benzopyrano6,7,8-ijquinolizin-11-one
    • (BENZOTHIAZOLYL)-TETRAHYDRO-TETRAMETHYL-BENZOPYROPYRANO QUINOLIZIN-11-ONE
    • 10-(2-Benzothiazolyl)-1,1,7,7-tetramethyl-2,3,6,7-
    • Coumarin545T
    • BenzothiazolyltetrahydrotetramethylHHbenzopyranoijquinolizinone
    • 1H,5H,11H-[1]Benzopyrano[6,7,8-ij]quinolizin-11-one,10-(2-benzothiazolyl)-2,3,6,7-tetrahydro-1,1,7,7-tetramethyl-
    • 10-(2-BENZOTHIAZOLYL)-2,3,6,7-TETRAHYDRO-1,1,7,7-TETRAMETHYL-1H,5H,11H-(1)-BENZOPYROPYRANO(6,7-8-I,J)QUINOLIZIN-11-ONE
    • X4214
    • 10-(2-Benzothiazolyl)-2,3,6,7-tetrahydro-1,1,7,7-tetramethyl-1H,5H,11H-[1]benzopyrano[6,7,8-ij]quinolizin-11-one
    • C545T, 2-Phenyl-9,10-di(naphthalen-2-yl)-anthracene
    • C545T , 10-(2-Benzothiazolyl)-2,3,6,7-. Molecular ForMula
    • 2,3,6,7-Tetrahydro-1,1,7,7,-tetramethyl-1H, 5H,11H-10-(2-benzothiazolyl)quinolizino[9,9a,1gh]coumarin
    • Coumarin 545T
    • C545T;X4214;Coumarin 545T
    • 10-(2-Benzothiazolyl
    • (ppy)2Ir(acac)
    • MSDMPJCOOXURQD-UHFFFAOYSA-N
    • BCP18976
    • C 545T
    • B4257
    • 10-(2-benzothiazolyl)-2 3 6 7
    • 10-(1,3-Benzothiazol-2-yl)-1,1,7,7-tetramethyl-2,3,6,7-tetrahydro- 1H,5H,11H-pyrano[3,2-g]pyrido[3,2,1- hi]quinoline
    • 10-(Benzo[d]thiazol-2-yl)-1,1,7,7-tetramethyl-2,3,6,7-tetrahydro-1H,5H,11H-pyrano[2,3-f]pyrido[3,2,1-ij]quinolin-11-one
    • SCHEMBL871160
    • 155306-71-1
    • FT-0653579
    • 3-NITRO-O-DIBROMOMETHYLBENZENE
    • 5-(1,3-BENZOTHIAZOL-2-YL)-10,10,16,16-TETRAMETHYL-3-OXA-13-AZATETRACYCLO[7.7.1.0(2),?.0(1)(3),(1)?]HEPTADECA-1,5,7,9(17)-TETRAEN-4-ONE
    • AKOS005145795
    • 1H,5H,11H-[1]Benzopyrano[6,7,8-ij]quinolizin-11-one, 10-(2-benzothiazolyl)-2,3,6,7-tetrahydro-1,1,7,7-tetramethyl-
    • 10-(2-benzothiazolyl)-1,1,7,7-tetramethyl-2,3,6,7-tetrahydro-1h,5h,11h-[1]benzopyrano[6,7,8-ij]quinolizin-11-one
    • Q27122962
    • 10-(2-BENZOTHIAZOLYL)-2 3 6 7-TETRAHYDR&;C545T
    • MFCD03427187
    • 2,3,6,7-Tetrahydro-1,1,7,7,-tetramethyl-1H,5H,11H-10-(2-
    • C-545T
    • 10-(2-Benzothiazolyl)-2,3,6,7-tetrahydro-1,1,7,7-tetramethyl-1H,5H,11H-(1)benzopyropyrano(6,7-8-I,j)
    • DTXSID60408462
    • 2,3,6,7-Tetrahydro-1,1,7,7,-tetramethyl-1H,5H,11H-10-(2-benzothiazolyl)quinol
    • A847603
    • 2,3,6,7-Tetrahydro-1,1,7,7-tetramethyl-1H,5H,11H-10-(2-benzothiazolyl)quinolizino[9,9a,1gh]coumarin
    • CHEBI:51896
    • benzothiazolyl)quinolizino[9,9a,1gh]coumarin
    • 5-(1,3-Benzothiazol-2-yl)-10,10,16,16-tetramethyl-3-oxa-13-azatetracyclo[7.7.1.02,7.013,17]heptadeca-1,5,7,9(17)-tetraen-4-one
    • 10-(2-Benzothiazolyl)-2,3,6,7-tetrahydro- 1,1,7,7-tetramethyl-1H,5H,11H-(1)benzopyropyrano (6,7-8-I,j)quinolizin -11-one
    • AS-75003
    • 10-(1,3-benzothiazol-2-yl)-1,1,7,7-tetramethyl-2,3,6,7-tetrahydro-1H,5H,11H-pyrano[2,3-f]pyrido[3,2,1-ij]quinolin-11-one
    • A12100
    • Bis[2-(2-pyridinyl-N)phenyl-C](acetylacetonato)iridium(III)
    • MDL: MFCD03427187
    • Inchi: 1S/C26H26N2O2S/c1-25(2)9-11-28-12-10-26(3,4)20-21(28)17(25)14-15-13-16(24(29)30-22(15)20)23-27-18-7-5-6-8-19(18)31-23/h5-8,13-14H,9-12H2,1-4H3
    • InChI Key: MSDMPJCOOXURQD-UHFFFAOYSA-N
    • SMILES: S1C2C=CC=CC=2N=C1C1C(=O)OC2C(C=1)=CC1=C3C=2C(C)(C)CCN3CCC1(C)C

Computed Properties

  • Exact Mass: 430.17100
  • Monoisotopic Mass: 430.17149925g/mol
  • Isotope Atom Count: 0
  • Hydrogen Bond Donor Count: 0
  • Hydrogen Bond Acceptor Count: 5
  • Heavy Atom Count: 31
  • Rotatable Bond Count: 1
  • Complexity: 792
  • Covalently-Bonded Unit Count: 1
  • Defined Atom Stereocenter Count: 0
  • Undefined Atom Stereocenter Count : 0
  • Defined Bond Stereocenter Count: 0
  • Undefined Bond Stereocenter Count: 0
  • Surface Charge: 0
  • XLogP3: 6.7
  • Topological Polar Surface Area: 70.7

Experimental Properties

  • Color/Form: Orange crystal
  • Density: 1.3±0.1 g/cm3
  • Melting Point: 225.0 to 229.0 deg-C
  • Boiling Point: 615.3±65.0 °C at 760 mmHg
  • Flash Point: 325.9±34.3 °C
  • PSA: 74.58000
  • LogP: 6.30370
  • Solubility: Not determined

Coumarin 545T Security Information

Coumarin 545T Pricemore >>

Related Categories No. Product Name Cas No. Purity Specification Price update time Inquiry
TI XI AI ( SHANG HAI ) HUA CHENG GONG YE FA ZHAN Co., Ltd.
B4257-200MG
Coumarin 545T
155306-71-1 >98.0%(N)
200mg
¥1390.00 2024-04-17
SHANG HAI A LA DING SHENG HUA KE JI GU FEN Co., Ltd.
C130046-250mg
Coumarin 545T
155306-71-1 98%
250mg
¥1199.90 2023-09-03
SHANG HAI A LA DING SHENG HUA KE JI GU FEN Co., Ltd.
C130046-1g
Coumarin 545T
155306-71-1 98%
1g
¥3699.90 2023-09-03
HE FEI BO MEI SHENG WU KE JI YOU XIAN ZE REN GONG SI
BB9522-100mg
Coumarin 545T
155306-71-1 ≥99%
100mg
¥1850元 2023-09-15
HE FEI BO MEI SHENG WU KE JI YOU XIAN ZE REN GONG SI
BB9522-1g
Coumarin 545T
155306-71-1 ≥99%
1g
¥5500元 2023-09-15
TRC
C755540-2.5mg
Coumarin 545T
155306-71-1
2.5mg
$ 50.00 2022-01-10
TRC
C755540-5mg
Coumarin 545T
155306-71-1
5mg
$184.00 2023-05-18
TRC
C755540-25mg
Coumarin 545T
155306-71-1
25mg
$839.00 2023-05-18
SHANG HAI MAI KE LIN SHENG HUA Technology Co., Ltd.
B838216-25g
(BENZOTHIAZOLYL)-TETRAHYDRO-TETRAMETHYL-BENZOPYROPYRANO QUINOLIZIN-11-ONE
155306-71-1 90 %
25g
376.00 2021-05-17
SHANG HAI MAI KE LIN SHENG HUA Technology Co., Ltd.
B871797-1g
(BENZOTHIAZOLYL)-TETRAHYDRO-TETRAMETHYL-BENZOPYROPYRANO QUINOLIZIN-11-ONE
155306-71-1 98%
1g
2,587.00 2021-05-17

Coumarin 545T Related Literature

Additional information on Coumarin 545T

Recent Advances in the Application of Coumarin 545T (155306-71-1) in Chemical Biology and Pharmaceutical Research

Coumarin derivatives have long been recognized for their versatile applications in chemical biology and pharmaceutical research. Among these, Coumarin 545T (CAS: 155306-71-1) has emerged as a particularly promising compound due to its unique photophysical properties and potential therapeutic applications. This research briefing aims to provide an overview of the latest advancements in the study of Coumarin 545T, focusing on its synthesis, characterization, and applications in drug discovery and biomedical imaging.

Recent studies have highlighted the exceptional fluorescence properties of Coumarin 545T, making it a valuable tool for bioimaging and diagnostic applications. Researchers have successfully utilized this compound as a fluorescent probe for tracking cellular processes, such as protein-protein interactions and intracellular signaling pathways. The high quantum yield and photostability of Coumarin 545T enable prolonged imaging sessions with minimal photobleaching, a critical advantage for live-cell imaging studies.

In the realm of drug discovery, Coumarin 545T has shown potential as a scaffold for developing novel therapeutic agents. Structural modifications of the coumarin core have yielded derivatives with enhanced bioavailability and target specificity. Notably, recent computational studies have explored the binding affinities of Coumarin 545T derivatives with various biological targets, including kinases and G-protein-coupled receptors, suggesting promising avenues for future drug development.

The synthesis and optimization of Coumarin 545T have also seen significant progress. Novel synthetic routes have been developed to improve yield and purity while reducing environmental impact. Green chemistry approaches, such as microwave-assisted synthesis and solvent-free reactions, have been successfully applied to the production of Coumarin 545T, aligning with the growing emphasis on sustainable pharmaceutical manufacturing.

Pharmacological evaluations of Coumarin 545T derivatives have revealed interesting biological activities, including anti-inflammatory, antioxidant, and antimicrobial properties. These findings have spurred further investigation into the compound's mechanism of action and potential clinical applications. Recent in vivo studies have demonstrated the compound's favorable pharmacokinetic profile and low toxicity, supporting its potential translation into therapeutic use.

Looking forward, researchers are exploring the integration of Coumarin 545T with emerging technologies such as nanotechnology and targeted drug delivery systems. Preliminary studies have shown that nanoparticle formulations incorporating Coumarin 545T can enhance drug solubility and tissue specificity while maintaining the compound's beneficial properties. These developments open new possibilities for precision medicine applications.

In conclusion, Coumarin 545T (155306-71-1) continues to be a compound of significant interest in chemical biology and pharmaceutical research. Its unique combination of photophysical properties and biological activities makes it a versatile tool for both basic research and therapeutic development. As synthetic methodologies advance and our understanding of its biological interactions deepens, we anticipate seeing more innovative applications of this compound in the coming years.

Recommended suppliers
Jiangxi Boyang Pharmaceutical Chemical Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Jiangxi Boyang Pharmaceutical Chemical Co., Ltd
鉅瀾化工科技(青島)有限公司
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
鉅瀾化工科技(青島)有限公司
Hangzhou Cedareal Technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Hangzhou Cedareal Technology Co., Ltd.
Shandong Feiyang Chemical Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Shandong Feiyang Chemical Co., Ltd
Zhejiang Brunova Technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Zhejiang Brunova Technology Co., Ltd.